Entering text into the input field will update the search result below

Evolus +2% premarket on revenue beat

Aug. 12, 2019 7:40 AM ETEvolus, Inc. (EOLS) StockEOLSBy: SA News Team
  • Evolus (EOLS) Q2 results: Revenues: $2.3M.
  • Net loss: ($37.6M) (-129.3%); loss/share: ($1.37) (-98.6%); Quick Assets: $99.9M (+7.2%).
  • The Company launched NEWTOX NOW $75 consumer coupon program on July 1, designed to accelerate Jeuveau conversion.
  • Evolus received a revised positive CHMP opinion for Nuceiva (prabotulinumtoxinA-xvfs) (branded as Jeuveau in U.S.) and now expect European approval in H2.
  • Shares are up 2% premarket.
  • Previously: Evolus EPS misses by $0.25, beats on revenue (Aug. 12)

Recommended For You

More Trending News

About EOLS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EOLS--
Evolus, Inc.